** Australian healthcare stocks .AXHJ fall as much as 1.4% - biggest intraday pct decline since June 23
** U.S. President Donald Trump says he will announce tariffs on pharmaceutical imports potentially at the end of July, starting with a 'low tariff' to give companies time to move their manufacturing units to the U.S. before imposing a 'very high tariff' in a year or so
** Australian pharmaceutical firms benefit significantly from U.S. sales
** Sector giant CSL CSL.AX falls 1.8% while Telix Pharmaceuticals TLX.AX down 0.7%
** Sub-index down 5.8% YTD vs 4.9% in broader benchmark .AXJO
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。